Name Funds
holding
Growth Growth % Return since
31 Mar ‘17
176
19 +3 +19% 97.5%
177
19 +3 +19% 43.7%
178
32 +5 +19% 11%
BLRX
179
BioLineRX
BLRX
$14.7M
26 +4 +18% 99.4%
180
13 +2 +18% 41.4%
181
59 +9 +18% 39.1%
182
99 +15 +18% 89.2%
183
33 +5 +18% 75.4%
184
33 +5 +18% 99.5%
185
47 +7 +18% 22.4%
UPGD icon
186
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$108M
27 +4 +17% 86.8%
187
69 +10 +17% 15.3%
188
28 +4 +17% 98%
189
28 +4 +17% 71.7%
190
21 +3 +17% 75.7%
191
21 +3 +17% 62.1%
192
21 +3 +17% 97.3%
193
21 +3 +17% 88.5%
194
14 +2 +17% 17.2%
195
14 +2 +17% 99.3%
196
7 +1 +17% 97.1%
197
7 +1 +17% 76.4%
198
7 +1 +17% 49.7%
199
7 +1 +17% 6.54%
200
7 +1 +17% 23.9%